Meyka Pro banner
Roche Holding AG

Roche Holding AG (ROP.SW) Stock Overview

Explore Roche Holding AG’s financial performance, market position, analyst ratings, and future outlook.

ROP.SWSIX
HealthcareDrug Manufacturers - General
CHF360.90
CHF4.80(1.35%)
Swiss Market opens in 10h 9m

Roche Holding AG (ROP.SW)

Meyka AI Score

Z

Key Financials

Market Cap287.3B
P/E Ratio23.18
EPS (TTM)$19.46
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$353.55
3 Months$373.97
1 Year Target$489.92

ROP.SW Stock Analysis & Investment Overview (SIX)

Our AI-powered analysis of Roche Holding AG (SIX: ROP.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Roche Holding AG's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ROP.SW on the SIX shows an RSI of 52.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $489.92 for the SIX listing.

Key metrics behind Roche Holding AG's SIX-traded stock include a P/E ratio of 23.18 and a market capitalization of 287.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ROP.SW on the SIX.

Price Performance (SIX: ROP.SW)

1-Day Change
1.35%
5-Day Change
-1.34%
1-Month Change
7.99%
3-Month Change
12.19%
6-Month Change
-2.27%
Year-to-Date (YTD) Change
10.88%
1-Year Change
40.98%
3-Year Change
41.50%
5-Year Change
-3.13%
All-Time (Max) Change
475.69%

Contact Information

41 61 688 11 11
Grenzacherstrasse 124, Basel, BS, 4070

Company Facts

1,032,490 Employees
IPO DateAug 20, 2003
CountryCH
Actively Trading

Frequently Asked Questions